Skip to main content
Clinical Trials/NCT00653809
NCT00653809CompletedNot Applicable

Elucidating the Role of Nitric Oxide and Endothelin-1 Activation in Endothelial Cells Co-cultured With Placental Explants From African-american and Caucasian High Risk Pregnancies

University of Mississippi Medical Center1 site in 1 country52 target enrollmentStarted: June 2007Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
52
Locations
1
Primary Endpoint
Nitric oxide and Endothelin-1 levels

Study Overview

Brief Summary

The goal of this study is to examine the activation of markers of endothelial and cardiovascular dysfunctions, from women with high-risk pregnancies. Information from this study will hopefully provide enough information to determine a link between race, the advent of high risk pregnancies and cardiovascular markers. With this information it might be possible to intervene with approved pharmacological treatments.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • African-american or Caucasian
  • Between ages of 18 - 40 years of age

Exclusion Criteria

  • Presence of a disease or condition which is not preeclampsia
  • Drug or alcohol abuse during pregnancy

Outcomes

Primary Outcomes

Nitric oxide and Endothelin-1 levels

Time Frame: 48 hours after tissue collection

Secondary Outcomes

  • Nitric oxide isoforms and Endothelin-1 receptor activation based on primary outcome(within 6 months from tissue collection)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kedra Wallace

Postdoc Research Fellow

University of Mississippi Medical Center

Study Sites (1)

Loading locations...

Similar Trials

Racial Differences: Nitric Oxide(NO) and... | Clinical Trial